Malley Thomas Insider Trading -- Recent SEC Form 4 Transactions
Malley Thomas (CIK 1403322) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-02). Recent activity: Buy KNSA (2,799 shares), Buy KURA (10,000 shares), Buy KNSA (21,959 shares), Buy KNSA (27,448 shares), Sell KNSA (49,407 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|
| 2026-06-02 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 2,799 | $0 |
| 2026-03-20 | Kura Oncology, Inc. (KURA) | Director | Buy | 10,000 | $31,200 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 21,959 | $40,844 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 27,448 | $104,302 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Sell | 49,407 | $1.6M |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 20,129 | $208,536 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 30,000 | $296,400 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Sell | 50,129 | $1.7M |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 18,760 | $290,217 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 33,237 | $476,286 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 26,236 | $398,525 |
| 2025-08-14 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Sell | 78,233 | $2.6M |
| 2025-06-05 | Kiniksa Pharmaceuticals International, plc (KNSA) | Director | Buy | 3,173 | $0 |
Source: SEC Form 4 filings · as of 2026-06-02